Picture of argenx SE logo

ARGX argenx SE News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapMomentum Trap

Brief: Argenx Q3 Total Operating Income $589 MLN

Oct 31 (Reuters) - argenx SE  ARGX.BR :
    * Q3 TOTAL OPERATING INCOME $ ‍589​ MLN
    * PHASE 1 STUDIES OF ARGX-213 AND ARGX-121 EXPECTED TO START
IN
SECOND HALF OF 2025
    * INVESTIGATIONAL NEW DRUG (IND) APPLICATIONS FOR ARGX-220
AND
ARGX-109 ON TRACK TO BE FILED BY END OF 2025

Source text:  ID:nGNE9PMWGJ 
Further company coverage:  ARGX.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on argenx SE

See all news